GSA Capital Partners’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $293K | Buy |
39,160
+4,409
| +13% | +$33K | 0.02% | 1268 |
|
|
2025
Q1 | $340K | Hold |
34,751
| – | – | 0.03% | 1059 |
|
|
2024
Q4 | $188K | Sell |
34,751
-15,378
| -31% | -$83.2K | 0.01% | 1430 |
|
|
2024
Q3 | $315K | Buy |
50,129
+1,790
| +4% | +$11.2K | 0.02% | 1190 |
|
|
2024
Q2 | $306K | Buy |
48,339
+9,057
| +23% | +$57.3K | 0.02% | 1273 |
|
|
2024
Q1 | $322K | Buy |
39,282
+11,969
| +44% | +$98.1K | 0.03% | 1176 |
|
|
2023
Q4 | $228K | Buy |
+27,313
| New | +$228K | 0.02% | 1253 |
|